Sunesis to Present at Upcoming Investor Conferences
Wells Fargo Healthcare Conference Wednesday, September 7th at 2:20 PM Eastern Time
Westin Boston Waterfront, Boston
- Rodman & Renshaw 18th Annual
Global Investment Conference Tuesday, September 13th at 2:10 PM Eastern Time
Lotte New York Palace Hotel,
Live webcasts of the presentations will be available on the Sunesis website at http://ir.sunesis.com. Replays of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the potential treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to improving the lives of people with cancer. Currently, the company is focused on pursuing regulatory approval in
For additional information on Sunesis, please visit http://www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
David Pitts Argot Partners212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc.650-266-3717